Department of Neurology, Charité Universitätsmedizin
Berlin, State of Berlin, Germany
NCT Number: NCT01219231
The researchers will investigate whether exercise could provide positive effects on general brain functions in elderly people with impaired glucose tolerance.
Looking for future studies?
Notify Me50 year–65 year
All sexes
Interventional
Phase 4
Berlin, State of Berlin, Germany
The age-related degradation of cognitive functions even to the point of neurodegenerative disorders such as Alzheimer's disease are a growing public-health concern with devastating effects.
Referring to animal data, empirical studies, and pilot human trials, exercise should improve cognitive functions such as learning and memory. To test this hypothesis, the researchers study general brain functions in elderly subjects (50-80 years old) with impaired glucose tolerance during a short term exercise program.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
6 months of aerobic exercise
Time frame: Prior to intervention and after 6 months of intervention
Time frame: Prior to intervention and after 6 months of intervention
Time frame: Prior to intervention and after 6 months of intervention
Charite University, Berlin, Germany
Other
Exercise in Elderly Individuals With Impaired Glucose Tolerance: Beneficial for Vasculature and Neurons?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01864460
Behavior, Diabetes
Baltimore, Maryland, United States
View Trial DetailsNCT05056376
Behavior, Body Weight
Baltimore, Maryland, United States
View Trial DetailsNCT00218998
Behavior, Body Weight
Trondheim, Norway
View Trial DetailsNCT03945435
Behavior, Glucose Intolerance
Boston, Massachusetts, United States
View Trial Details